{"retracted":false,"update":{"timestamp":1391299200000,"doi":"10.1007/s10072-014-1649-0","type":"correction"},"doi":"10.1007/s10072-013-1616-1","journal":"Neurological Sciences","publisher":"Springer Nature","title":"Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group"}
